Clinical Trial Update: IL13 Signaling in Allergic Asthma

View source ↗

Summary

A Duke University–sponsored clinical trial evaluating IL-13 signaling in allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Asthma

Snippet

Sponsor: Duke University | Conditions: Asthma, Allergic, Asthma | Status: COMPLETED